Estetrol/Drospirenone to Reduce the Average Size of Endometriomas

Recruiting

Estetrol/DrospirenoneEstetrol/Drospirenone to Reduce the Average Size of Endometriomas

Sponsor:

Andrew Zakhari

Code:

NCT05837624

Conditions

Ovarian Endometrioma

Endometrioma

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Estetrol/Drospirenone

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Andrew Zakhari on 2025-04-06.